Telehealth during COVID‐19 restrictions in patients with cardiovascular disease: impact on medication prescriptions and patient satisfaction

Nestor Gahungu,Nick S. R. Lan,Sameera Gamalath,Jane Phan,Vikas Bhat,Rhys Spencer,Sarah A. Hitchen,James M. Rankin,Girish Dwivedi,Abdul Rahman Ihdayhid
DOI: https://doi.org/10.1111/imj.16378
2024-03-21
Internal Medicine Journal
Abstract:Background and Aims Telehealth plays an integral part in healthcare delivery. The impact of telehealth and the COVID‐19 pandemic on medication prescribing and patient satisfaction with telehealth in cardiology clinics remains unknown. Methods A retrospective study of cardiology clinic patients at an Australian tertiary hospital was conducted; 630 patients seen before the COVID‐19 pandemic (0.6% telehealth) and 678 during the pandemic (91.2% telehealth) were included. Medication changes, new prescriptions and time to obtaining prescriptions after clinic were compared. To evaluate patients' experiences, cardiology clinic patients reviewed during the pandemic were prospectively invited to participate in an electronic survey sent to their mobile phones. Results The overall rates of medication changes made in the clinic between the prepandemic and the pandemic periods did not differ significantly (26.9% vs 25.8%). Compared with prepandemic, new cardiac medication prescriptions during clinic were significantly less (9.3% vs 2.5%; P
medicine, general & internal
What problem does this paper attempt to address?